Search Within

Irene Y Cheung

  1. "Govindaswami Ragupathi"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (3)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (7)
  2. Center for Molecular Imaging and Biotechnology (CMIB) (7)
  3. Department of Medicine (7)
  4. GSK Faculty (7)
  5. General Oncology Service (7)
  6. Melanoma Disease Management Team (7)

More Groups

People
  1. Brian Kushner (7)
  2. Govindaswami Ragupathi (7)
  3. Nai-Kong Cheung (7)
  4. Shakeel Modak (7)
  5. Audrey Mauguen (6)
  6. Stephen Roberts (5)

More People

Years
  1. 2023 (2)
  2. 2022 (1)
  3. 2021 (2)
  4. 2020 (1)
  5. 2014 (1)
Publications
  1. Cancer Research (2)
  2. Cancers (1)
  3. Clinical Cancer Research (1)
  4. JAMA Oncology (1)
  5. Journal of Clinical Oncology (1)
  6. Pediatric Blood and Cancer (1)
Publishers
  1. American Association for Cancer Research (3)
  2. American Medical Association (1)
  3. American Society of Clinical Oncology (1)
  4. MDPI (1)
  5. Wiley Periodicals, Inc (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Gut microbiota associations with GD2/GD3 vaccine response in patients with high-risk neuroblastoma
    Meeting Abstract

    Miltiadous, O.; Nguyen, C.; Cheung, I.; Kushner, B.; Mauguen, A.; Waters, N.; Dai, A.; Kivovich, V.; Littmann, E.; Harford, L.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Effect of oral β-glucan on antibody response to ganglioside vaccine in patients with high-risk neuroblastoma: A phase 2 randomized clinical trial
    Journal Article

    Cheung, I. Y.; Mauguen, A.; Modak, S.; Ragupathi, G.; Basu, E. M.; Roberts, S. S.; Kushner, B. H.; Cheung, N. K.
    JAMA Oncology (2023)

    Fulltext@MSK | Save
  • Oral beta-glucan enhanced anti-ganglioside antibody titer after vaccination against high- risk neuroblastoma: Results of a randomized trial
    Meeting Abstract

    Cheung, I. Y.; Mauguen, A.; Feng, Y.; Ragupathi, G.; Basu, E.; Roberts, S. S.; Modak, S.; Kushner, B. H.; Cheung, N. K. V.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Phase I trial of oral yeast-derived β-glucan to enhance anti-GD2 immunotherapy of resistant high-risk neuroblastoma
    Journal Article

    Iglesias Cardenas, F.; Mauguen, A.; Cheung, I. Y.; Kramer, K.; Kushner, B. H.; Ragupathi, G.; Cheung, N. K. V.; Modak, S.
    Cancers (2021)

    Fulltext@MSK | Save
  • Survival impact of anti-GD2 antibody response in a phase II ganglioside vaccine trial among patients with high-risk neuroblastoma with prior disease progression
    Journal Article

    Cheung, I. Y.; Cheung, N. K. V.; Modak, S.; Mauguen, A.; Feng, Y.; Basu, E.; Roberts, S. S.; Ragupathi, G.; Kushner, B. H.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Survival impact of anti-GD2 antibody response - A phase II ganglioside vaccine trial in relapsed neuroblastoma
    Meeting Abstract

    Cheung, I. Y.; Cheung, N. K. V.; Modak, S.; Mauguen, A.; Basu, E.; Roberts, S. S.; Ragupathi, G.; Kushner, B. H.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Phase I trial of a bivalent gangliosides vaccine in combination with β-glucan for high-risk neuroblastoma in second or later remission
    Journal Article

    Kushner, B. H.; Cheung, I. Y.; Modak, S.; Kramer, K.; Ragupathi, G.; Cheung, N. K. V.
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save